Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome.
作者:
主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);消炎药(Anti-Inflammatory Agents);抗病毒药(Antiviral Agents);病例对照研究(Case-Control Studies);队列研究(Cohort Studies);秋水仙碱(Colchicine);冠状病毒感染(Coronavirus Infections);地塞米松(Dexamethasone);复方合剂(Drug Combinations);酶抑制剂(Enzyme Inhibitors);女(雌)性(Female);住院(Hospitalization);人类(Humans);羟氯喹(Hydroxychloroquine);意大利(Italy);男(雄)性(Male);中年人(Middle Aged);疾病大流行(Pandemics);肺炎, 病毒性(Pneumonia, Viral);比例危险度模型(Proportional Hazards Models);利托纳韦(Ritonavir);存活率(Survival Rate)
DOI
10.1136/annrheumdis-2020-217712
PMID
32732245
发布时间
2023-11-12
- 浏览0

Annals of the rheumatic diseases
1286-1289页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文